| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 医药批发(元) | 389,761,529.52 | 186,839,750.15 | 574,028,328.57 | 255,144,559.75 |
| 医药生产(元) | - | 928,381,757.81 | - | 1,147,961,858.47 |
| 医药生产-儿科类(元) | 635,593,986.59 | - | 823,645,627.70 | - |
| 医药生产-妇科类(元) | 11,985,858.40 | - | 18,855,228.40 | - |
| 医药生产-精神神经类(元) | 185,414,722.67 | - | 156,864,501.84 | - |
| 医药生产-抗感染类(元) | 41,992,196.75 | - | 37,874,120.72 | - |
| 医药生产-内分泌系统类(元) | 65,866,818.15 | - | 81,700,353.87 | - |
| 医药生产-消化系统(元) | 102,700,133.42 | - | 93,769,251.33 | - |
| 医药生产-心血管系统类(元) | 455,415,522.98 | - | 525,799,786.65 | - |
| 医药生产-原料药(元) | 94,725,143.66 | - | 95,899,624.94 | - |
| 医药生产-止痛类(元) | 86,870,275.88 | - | 72,447,299.82 | - |
| 医药生产-其他(元) | 115,834,737.76 | - | 120,043,250.07 | - |
| 其他贸易(元) | 23,874,058.11 | 8,672,196.73 | 50,589,281.84 | 26,858,010.56 |
| 营业成本(元) | ||||
| 医药批发(元) | 363,796,699.87 | 178,784,543.54 | 541,250,998.67 | 235,146,048.45 |
| 医药生产(元) | - | 339,681,757.77 | - | 394,600,541.07 |
| 医药生产-儿科类(元) | 149,828,073.29 | - | 201,582,678.95 | - |
| 医药生产-妇科类(元) | 7,829,725.69 | - | 8,316,027.76 | - |
| 医药生产-精神神经类(元) | 68,509,310.50 | - | 55,720,101.77 | - |
| 医药生产-抗感染类(元) | 36,687,418.03 | - | 29,668,214.12 | - |
| 医药生产-内分泌系统类(元) | 17,119,899.00 | - | 24,223,729.03 | - |
| 医药生产-消化系统(元) | 22,149,759.63 | - | 18,929,954.01 | - |
| 医药生产-心血管系统类(元) | 161,040,200.87 | - | 172,995,155.41 | - |
| 医药生产-原料药(元) | 43,872,737.28 | - | 51,006,292.69 | - |
| 医药生产-止痛类(元) | 71,190,078.86 | - | 51,959,708.61 | - |
| 医药生产-其他(元) | 79,572,767.81 | - | 71,368,153.51 | - |
| 其他贸易(元) | 17,190,920.76 | 6,377,782.97 | 40,830,968.45 | 17,737,670.77 |
| 毛利(元) | ||||
| 医药批发(元) | 25,964,829.65 | 8,055,206.61 | 32,777,329.90 | 19,998,511.30 |
| 医药生产(元) | - | 588,700,000.04 | - | 753,361,317.40 |
| 医药生产-儿科类(元) | 485,765,913.30 | - | 622,062,948.75 | - |
| 医药生产-妇科类(元) | 4,156,132.71 | - | 10,539,200.64 | - |
| 医药生产-精神神经类(元) | 116,905,412.17 | - | 101,144,400.07 | - |
| 医药生产-抗感染类(元) | 5,304,778.72 | - | 8,205,906.60 | - |
| 医药生产-内分泌系统类(元) | 48,746,919.15 | - | 57,476,624.84 | - |
| 医药生产-消化系统(元) | 80,550,373.79 | - | 74,839,297.32 | - |
| 医药生产-心血管系统类(元) | 294,375,322.11 | - | 352,804,631.24 | - |
| 医药生产-原料药(元) | 50,852,406.38 | - | 44,893,332.25 | - |
| 医药生产-止痛类(元) | 15,680,197.02 | - | 20,487,591.21 | - |
| 医药生产-其他(元) | 36,261,969.95 | - | 48,675,096.56 | - |
| 其他贸易(元) | 6,683,137.35 | 2,294,413.76 | 9,758,313.39 | 9,120,339.79 |
| 毛利率(%) | ||||
| 医药批发(%) | 6.66 | 4.31 | 5.71 | 7.84 |
| 医药生产(%) | - | 63.41 | - | 65.63 |
| 医药生产-儿科类(%) | 76.43 | - | 75.53 | - |
| 医药生产-妇科类(%) | 34.68 | - | 55.90 | - |
| 医药生产-精神神经类(%) | 63.05 | - | 64.48 | - |
| 医药生产-抗感染类(%) | 12.63 | - | 21.67 | - |
| 医药生产-内分泌系统类(%) | 74.01 | - | 70.35 | - |
| 医药生产-消化系统(%) | 78.43 | - | 79.81 | - |
| 医药生产-心血管系统类(%) | 64.64 | - | 67.10 | - |
| 医药生产-原料药(%) | 53.68 | - | 46.81 | - |
| 医药生产-止痛类(%) | 18.05 | - | 28.28 | - |
| 医药生产-其他(%) | 31.30 | - | 40.55 | - |
| 其他贸易(%) | 27.99 | 26.46 | 19.29 | 33.96 |
| 收入构成(%) | ||||
| 医药批发(%) | 17.64 | 16.62 | 21.65 | 17.84 |
| 医药生产(%) | - | 82.60 | - | 80.28 |
| 医药生产-儿科类(%) | 28.76 | - | 31.06 | - |
| 医药生产-妇科类(%) | 0.54 | - | 0.71 | - |
| 医药生产-精神神经类(%) | 8.39 | - | 5.92 | - |
| 医药生产-抗感染类(%) | 1.90 | - | 1.43 | - |
| 医药生产-内分泌系统类(%) | 2.98 | - | 3.08 | - |
| 医药生产-消化系统(%) | 4.65 | - | 3.54 | - |
| 医药生产-心血管系统类(%) | 20.61 | - | 19.83 | - |
| 医药生产-原料药(%) | 4.29 | - | 3.62 | - |
| 医药生产-止痛类(%) | 3.93 | - | 2.73 | - |
| 医药生产-其他(%) | 5.24 | - | 4.53 | - |
| 其他贸易(%) | 1.08 | 0.77 | 1.91 | 1.88 |
| 毛利构成(%) | ||||
| 医药批发(%) | 2.22 | 1.34 | 2.37 | 2.56 |
| 医药生产(%) | - | 98.27 | - | 96.28 |
| 医药生产-儿科类(%) | 41.47 | - | 44.96 | - |
| 医药生产-妇科类(%) | 0.35 | - | 0.76 | - |
| 医药生产-精神神经类(%) | 9.98 | - | 7.31 | - |
| 医药生产-抗感染类(%) | 0.45 | - | 0.59 | - |
| 医药生产-内分泌系统类(%) | 4.16 | - | 4.15 | - |
| 医药生产-消化系统(%) | 6.88 | - | 5.41 | - |
| 医药生产-心血管系统类(%) | 25.13 | - | 25.50 | - |
| 医药生产-原料药(%) | 4.34 | - | 3.24 | - |
| 医药生产-止痛类(%) | 1.34 | - | 1.48 | - |
| 医药生产-其他(%) | 3.10 | - | 3.52 | - |
| 其他贸易(%) | 0.57 | 0.38 | 0.71 | 1.17 |